EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The antimalarial drug, Ro 42-1611 (arteflene), does not affect cytoadherence and cytokine-inducing properties of Plasmodium falciparum malaria parasites


Tropical Medicine and Parasitology 46(2): 88-92
The antimalarial drug, Ro 42-1611 (arteflene), does not affect cytoadherence and cytokine-inducing properties of Plasmodium falciparum malaria parasites
The ability of the antimalarial drug, Ro 42-1611 to block parasite mediated cytokine induction in vitro as well as cytoadherence of infected erythrocytes to melanoma cells in vitro was investigated. The biological activity of Ro 42-1611 was confirmed as it blocked Plasmodium falciparum growth in cultures. Ro 42-1611 had no major effect on TNF, IL- alpha or IL-6 cytokine release from mononuclear cells stimulated with malaria antigens or lipopolysaccharide and it did not affect cell viability.


Accession: 002709840

PMID: 8525291



Related references

A study on the proper dose of the drug Ro 42-1611 (arteflene) in the treatment of falciparum malaria. Revista da Sociedade Brasileira de Medicina Tropical 31(3): 323-324, 1998

Antimalarial drugs affect cytoadherence and rosetting of Plasmodium falciparum in vitro Biological and theoretical implications. American Journal of Tropical Medicine & Hygiene 47(4 SUPPL ): 90-91, 1992

The biomimetic iron-mediated degradation of arteflene (Ro-42-1611), an endoperoxide antimalarial: implications for the mechanism of antimalarial activity. Tetrahedron Letters 38(24): 4263-4266, 1997

Cytoadherence phenotype of Plasmodium falciparum-infected erythrocytes is associated with specific pfemp-1 expression in parasites from children with cerebral malaria. Malaria Journal 13(): 333-333, 2015

Animal pharmacokinetics and metabolism of the new antimalarial Ro 42-1611 (arteflene). Tropical Medicine and Parasitology 45(3): 272-277, 1994

Proceedings of the Symposium Arteflene (Ro 42-1611); a new effective antimalarial. Tropical Medicine and Parasitology 45(3): 259-291, 1994

Ro 42-1611 (arteflene), a new effective antimalarial: chemical structure and biological activity. Tropical Medicine and Parasitology 45(3): 261-265, 1994

Antimalarial activity of the bicyclic peroxide Ro 42-1611 (arteflene) in experimental models. Tropical Medicine and Parasitology 45(3): 266-271, 1994

Characterization of the Main Radical and Products Resulting from a Reductive Activation of the Antimalarial Arteflene (Ro 42-1611). Journal of Organic Chemistry 64(18): 6776-6781, 2001

Arteflene compared with mefloquine for treating Plasmodium falciparum malaria in children. American Journal of Tropical Medicine and Hygiene 55(3): 259-262, 1996